Holocene Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,204,538
Closed -$6.4M 697
2023
Q3
$6.4M Sell
1,204,538
-235,498
-16% -$1.25M 0.03% 341
2023
Q2
$13.7M Sell
1,440,036
-629,141
-30% -$6M 0.06% 233
2023
Q1
$22.8M Buy
2,069,177
+924,034
+81% +$10.2M 0.11% 185
2022
Q4
$16.9M Buy
1,145,143
+1,004,141
+712% +$14.9M 0.1% 198
2022
Q3
$2.7M Buy
+141,002
New +$2.7M 0.02% 360